Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Hu, Jiong
[Clear All Filters]
2024
Wang L
,
Xu G
,
Wang L
,
Jiang J
,
Gao W
,
Wan M
,
Blaise D
,
Hu J
.
Post-transplant cyclophosphamide at 80 mg/kg with low dose post-engraftment anti-thymocyte globulin in haploidentical transplantation with myeloablative conditioning.
Bone Marrow Transplant. 2024.
PubMed
Google Scholar
2023
Long J
,
Chen X
,
Shen Y
,
Lei Y
,
Mu L
,
Wang Z
,
Xiang R
,
Gao W
,
Wang L
,
Wang L
, et al.
A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment.
Cell Rep Med. 2023:101286.
PubMed
Google Scholar
Jiang J-L
,
Gao W-H
,
Wang L-N
,
Wan M
,
Wang L
,
Hu J
.
Low incidence of relapse with moderate conditioning regimen of fludarabine, busulfan and melphalan for patients with myeloid malignancies: a single-center analysis of 100 patients.
Transplant Cell Ther. 2023.
PubMed
Google Scholar
2020
Qian J-J
,
Hu X
,
Wang Y
,
Zhang Y
,
Du J
,
Yang M
,
Tong H
,
Bin Qian W-
,
Wei J
,
Yu W
, et al.
CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study.
Cancer Med. 2020.
PubMed
Google Scholar
Gao L
,
Zhang Y
,
Wang S
,
Kong P
,
Su Y
,
Hu J
,
Jiang M
,
Bai H
,
Lang T
,
Wang J
, et al.
Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial.
J Clin Oncol. 2020:JCO1903277.
PubMed
Google Scholar
2019
Li X
,
Dong Y
,
Li Y
,
Ren R
,
Wu W
,
Zhu H
,
Zhang Y
,
Hu J
,
Li J
.
Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study.
BMC Cancer. 2019;19(1):819.
PubMed
Google Scholar
Sun Y
,
Huang J
,
Hao C
,
Li Z
,
Liang W
,
Zhang W
,
Chen B
,
Yang W
,
Hu J
.
Population pharmacokinetic analysis of intravenous busulfan: GSTA1 genotype is not a predictive factor of initial dose in Chinese adult patients undergoing hematopoietic stem cell transplantation.
Cancer Chemother Pharmacol. 2019.
PubMed
Google Scholar
2013
Wang L
,
Wang Y
,
Tang W
,
Dou H-B
,
Shan J-H
,
Hu J
.
The superiority of allogeneic hematopoietic stem cell transplantation from unrelated donor over chemotherapy for adult patients with high-risk acute lymphoblastic leukemia in first remission.
Int J Hematol. 2013.
PubMed
Google Scholar